Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever

Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever

Lassa hemorrhagic fever is an acute human infectious disease with high mortality rate and pandemic potential. To date, there are no approved drugs for the specific treatment or prevention of Lassa hemorrhagic fever in the world. The aim of this study was to develop and evaluate the immunobiological...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Popova, O. V. Zubkova, T. A. Ozharovskaia, D. I. Zrelkin, D. V. Voronina, P. P. Goldovskaya, V. Yu. Kan, I. V. Dolzhikova, A. V. Kovyrshina, D. M. Grousova, I. A. Ermolova, D. V. Shcheblyakov, D. Yu. Logunov, A. L. Gintsburg
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2025-01-01
Series:Медицинская иммунология
Subjects:
lassa hemorrhagic fever
vaccine
adenovirus vector
human adenovirus
immunogenicity
safety assessment
Online Access:https://www.mimmun.ru/mimmun/article/view/2988
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mimmun.ru/mimmun/article/view/2988

Similar Items